LG Energy Solution Shares Surge 16 on Major US Battery Storage Deal Momentus Stock Surges as Space Company Secures Additional Funding Through Private Placement Indian LRS Outflows Jump Over 10 in March 2026 as Investments and Deposits Surge VF Corporation Draws Jim Cramers Attention as Potential Fantastic Buying Opportunity After Earnings Dip Bruno Mars Ties Taylor Swifts Billboard Record ChartTopping Milestone Reinforces Artist Revenue Potential SpaceX IPO Filing Highlights Growing Dependence on Starlink for Revenue and Profit AnaptysBio Inc ANAB Q1 2026 Earnings Significant EPS Miss Amid Clinical Progress Piper Sandler PIPR Q1 2026 Earnings EPS Surpasses Expectations with 512 Beat ICCC Q1 2026 Earnings Profitability Achieved with EPS of 021 Shares Dip 69 RBLX Q1 2026 Earnings EPS Surprise of 3531 Beats Estimates Despite Loss CDLX Q1 2026 Earnings Strong EPS Beat Driven by Cost Discipline Revenue Remains Under Wraps KORE Q1 2026 Earnings Massive EPS Miss Highlights Cost Pressures FMY Sees Modest Uptick Amid Stabilizing Mortgage Income Fund Performance CoStar Group Edges Lower as Market Digests Real Estate Headwinds CNB Financial Corporation CCNE Shows Modest Gain Consolidating Near Key Levels Cantaloupe Inc CTLP Holds at 1120 as Market Weighs Support and Resistance AbCellera Biologics ABCL Bounces from Support Biotech Stock Gains 173 on Renewed Interest Champion Homes Releases Q4 Fiscal 2026 Earnings Transcript Amid Housing Market Shifts NVMI Q1 2026 Earnings EPS Beats Estimates Stock Edges Lower Exzeo Group Inc XZO Gains 386 as Shares Approach Key Resistance Level BURL Q1 2026 Earnings EPS Beats Estimates Stock Rises 268 BJRI Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher ThredUp Q1 2026 Earnings NarrowerThanExpected Loss Fails to Lift Stock Schneider National Q1 2026 Earnings EPS Surpasses Expectations on Strong Cost Control UiPath Q1 2026 Earnings EPS Beat Drives Positive Sentiment Despite Revenue Ambiguity SIM Q1 2023 Earnings EPS Misses Estimates by Wide Margin SVRA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Pipeline Progress